High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)
NCT07700030 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2026-07-13
Summary
The primary objective of this study is to examine the effects of a high-protein diet (HP) paired with resistance training (RT) compared with a HP diet alone, on skeletal muscle mass (SMM) volume of the (a) quadriceps and (b) rhomboids, and upper and lower body muscle strength in adults recently prescribed tirzepatide. The secondary objectives of this study are to compare changes in resting energy expenditure (REE), adaptive thermogenesis (AT), and body adiposity (SFV, VAT, and intramuscular FF) in the quadriceps and rhomboid muscles) between the high-protein diet with RT and the high-protein diet arms at 6 months.
Conditions
Interventions
- OTHER
-
High protein diet
The standardized highprotein diet counseling focuses on achieving 2.5 g/kg FFM/day of dietary protein through food and commercially available protein powder supplements that will be provided to participants.
- BEHAVIORAL
-
Resistance Training (RT) Programs
Supervised RT program designed for muscle hypertrophy (2 sessions/week, \~45-60 minutes each)
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Collin Popp, PhD · NYU Langone Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-31
- Primary Completion
- 2027-11-30
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Adrenocorticotropic Hormone (ACTH) Stimulation and G Protein
NCT00196001 ·Status: COMPLETED
-
Growth Hormone Use in Adults With Prader-Willi Syndrome
NCT00444964 ·Status: COMPLETED ·Phase: PHASE3
-
304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
NCT00362063 ·Status: UNKNOWN ·Phase: NA
-
Effects of GH and Lirglutide on AgRP
NCT05681299 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
NCT03878992 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Growth Hormone (GH) on Lipid Depots
NCT00491582 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)
NCT01605331 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis
NCT02124070 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Glucocorticoid Receptor Antagonism in Subclinical Cushings
NCT00721201 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
NCT01410799 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Adults With Growth Hormone Deficiency
NCT00294619 ·Status: COMPLETED ·Phase: PHASE3
-
rHGH and Intestinal Permeability in Intestinal Failure
NCT01380366 ·Status: COMPLETED ·Phase: PHASE4
-
Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents
NCT02726542 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates
NCT00517062 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
NCT00720616 ·Status: WITHDRAWN ·Phase: NA
-
Growth Hormone for the Treatment of Gastroparesis
NCT06803589 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition
NCT03111810 ·Status: COMPLETED ·Phase: PHASE2
-
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
NCT00324064 ·Status: COMPLETED ·Phase: NA
-
Lipolytic Effects of GH in Hypopituitary Patients in Vivo
NCT02782208 ·Status: COMPLETED ·Phase: NA
-
Administration of Kisspeptin in Patients With Hyperprolactinemia
NCT02956447 ·Status: COMPLETED ·Phase: PHASE2
-
GH and Cardiovascular Risk Factors
NCT01877512 ·Status: COMPLETED ·Phase: PHASE4
-
Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy
NCT03554265 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
NCT03053271 ·Status: TERMINATED ·Phase: PHASE2
-
Mechanism of Growth Hormone Effects on Adipose Tissue
NCT00453557 ·Status: COMPLETED ·Phase: PHASE4